[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=c2130d7ffe3ed56fad8d00f72027a5984c046a010530728fbc2b2451cb646325",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730997720,
      "headline": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "id": 131193878,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=c2130d7ffe3ed56fad8d00f72027a5984c046a010530728fbc2b2451cb646325"
    }
  },
  {
    "ts": null,
    "headline": "Geron: A Post Earnings And Funding Announcement Assessment",
    "summary": "Geron Corporation's Rytelo gains FDA approval for MDS treatment, with promising sales and positive analyst outlook. Click here for this update of GERN stock prospects.",
    "url": "https://finnhub.io/api/news?id=8b4786e75da1f2268e87a48202ddd48db389b6526aa59754dd0bc8a9d12e4f84",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730984509,
      "headline": "Geron: A Post Earnings And Funding Announcement Assessment",
      "id": 131165998,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155151969/image_155151969.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Geron Corporation's Rytelo gains FDA approval for MDS treatment, with promising sales and positive analyst outlook. Click here for this update of GERN stock prospects.",
      "url": "https://finnhub.io/api/news?id=8b4786e75da1f2268e87a48202ddd48db389b6526aa59754dd0bc8a9d12e4f84"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Bristol-Myers Squibb (NYSE:BMY) Can Manage Its Debt Responsibly",
    "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
    "url": "https://finnhub.io/api/news?id=a713623bab7ceab23d86b11c35c1f33082a33046b8ffe9c9b9de94462f76fcb7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730977212,
      "headline": "Here's Why Bristol-Myers Squibb (NYSE:BMY) Can Manage Its Debt Responsibly",
      "id": 131171492,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/61ae5b4abdbb9c040fe4f1989e525046",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
      "url": "https://finnhub.io/api/news?id=a713623bab7ceab23d86b11c35c1f33082a33046b8ffe9c9b9de94462f76fcb7"
    }
  }
]